Terms: = Lymphoma AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286
43 results:
1. Tiam1 methylation by nsd2 promotes Rac1 signaling activation and colon cancer metastasis.
Song D; Hu F; Huang C; Lan J; She X; Zhao C; Wu H; Liu A; Wu Q; Chen Y; Luo X; Feng Y; Yang X; Xu C; Hu J; Wang G
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2305684120. PubMed ID: 38113258
[TBL] [Abstract] [Full Text] [Related]
2. Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report.
Zhang XY; Li J; Chen SL; Li Y; Wang H; He JH
Diagn Pathol; 2023 Aug; 18(1):97. PubMed ID: 37644531
[TBL] [Abstract] [Full Text] [Related]
3. nsd2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization.
Narang S; Evensen NA; Saliba J; Pierro J; Loh ML; Brown PA; Kolekar P; Mulder H; Shao Y; Easton J; Ma X; Tsirigos A; Carroll WL
Genome Biol; 2023 Apr; 24(1):64. PubMed ID: 37016431
[TBL] [Abstract] [Full Text] [Related]
4. Mouse models of human multiple myeloma subgroups.
Winkler W; Farré Díaz C; Blanc E; Napieczynska H; Langner P; Werner M; Walter B; Wollert-Wulf B; Yasuda T; Heuser A; Beule D; Mathas S; Anagnostopoulos I; Rosenwald A; Rajewsky K; Janz M
Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2219439120. PubMed ID: 36853944
[TBL] [Abstract] [Full Text] [Related]
5. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
6. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
Fend F; Dogan A; Cook JR
Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
[TBL] [Abstract] [Full Text] [Related]
7. Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments.
Jain P; Wang ML
Am J Hematol; 2022 May; 97(5):638-656. PubMed ID: 35266562
[TBL] [Abstract] [Full Text] [Related]
8. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
Tamai M; Kasai S; Akahane K; Thu TN; Kagami K; Komatsu C; Abe M; Watanabe A; Goi K; Miyake K; Inaba T; Takita J; Goto H; Minegishi M; Iwamoto S; Sugita K; Inukai T
J Steroid Biochem Mol Biol; 2022 Apr; 218():106068. PubMed ID: 35124168
[TBL] [Abstract] [Full Text] [Related]
9. Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
Yi S; Yan Y; Jin M; Bhattacharya S; Wang Y; Wu Y; Yang L; Gine E; Clot G; Chen L; Yu Y; Zou D; Wang J; Phan AT; Cui R; Li F; Sun Q; Zhai Q; Wang T; Yu Z; Liu L; Liu W; Lyv R; Sui W; Huang W; Xiong W; Wang H; Li C; Xiao Z; Hao M; Wang J; Cheng T; Bea S; Herrera AF; Danilov A; Campo E; Ngo VN; Qiu L; Wang L
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34882582
[TBL] [Abstract] [Full Text] [Related]
10. Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.
Antić Ž; Yu J; Bornhauser BC; Lelieveld SH; van der Ham CG; van Reijmersdal SV; Morgado L; Elitzur S; Bourquin JP; Cazzaniga G; Eckert C; Camós M; Sutton R; Cavé H; Moorman AV; Sonneveld E; Geurts van Kessel A; van Leeuwen FN; Hoogerbrugge PM; Waanders E; Kuiper RP
Pediatr Blood Cancer; 2022 Jan; 69(1):e29361. PubMed ID: 34597466
[TBL] [Abstract] [Full Text] [Related]
11. Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives.
Shrestha A; Kim N; Lee SJ; Jeon YH; Song JJ; An H; Cho SJ; Kadayat TM; Chin J
J Med Chem; 2021 Oct; 64(20):14913-14929. PubMed ID: 34488340
[TBL] [Abstract] [Full Text] [Related]
12. PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by
Li J; Hlavka-Zhang J; Shrimp JH; Piper C; Dupéré-Richér D; Roth JS; Jing D; Casellas Román HL; Troche C; Swaroop A; Kulis M; Oyer JA; Will CM; Shen M; Riva A; Bennett RL; Ferrando AA; Hall MD; Lock RB; Licht JD
Cancer Discov; 2022 Jan; 12(1):186-203. PubMed ID: 34417224
[TBL] [Abstract] [Full Text] [Related]
13. Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.
Kawashima I; Oishi N; Kasai K; Inoue T; Hosokawa E; Nakadate A; Matsuura M; Kumagai T; Koshiishi M; Yamamoto T; Nakajima K; Tanaka M; Kondo T; Kirito K
Virchows Arch; 2022 May; 480(5):1101-1105. PubMed ID: 34226971
[TBL] [Abstract] [Full Text] [Related]
14. Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations.
Antić Ž; Yu J; Van Reijmersdal SV; Van Dijk A; Dekker L; Segerink WH; Sonneveld E; Fiocco M; Pieters R; Hoogerbrugge PM; Van Leeuwen FN; Van Kessel AG; Waanders E; Kuiper RP
Haematologica; 2021 Dec; 106(12):3046-3055. PubMed ID: 33147938
[TBL] [Abstract] [Full Text] [Related]
15. Proteosomal degradation of nsd2 by BRCA1 promotes leukemia cell differentiation.
Park JW; Kang JY; Hahm JY; Kim HJ; Seo SB
Commun Biol; 2020 Aug; 3(1):462. PubMed ID: 32826945
[TBL] [Abstract] [Full Text] [Related]
16. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
[TBL] [Abstract] [Full Text] [Related]
17. The nsd2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia.
Pierro J; Saliba J; Narang S; Sethia G; Saint Fleur-Lominy S; Chowdhury A; Qualls A; Fay H; Kilberg HL; Moriyama T; Fuller TJ; Teachey DT; Schmiegelow K; Yang JJ; Loh ML; Brown PA; Zhang J; Ma X; Tsirigos A; Evensen NA; Carroll WL
Mol Cancer Res; 2020 Aug; 18(8):1153-1165. PubMed ID: 32332049
[TBL] [Abstract] [Full Text] [Related]
18. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.
Jain P; Zhang S; Kanagal-Shamanna R; Ok CY; Nomie K; Gonzalez GN; Gonzalez-Pagan O; Hill HA; Lee HJ; Fayad L; Westin J; Nastoupil L; Hagemeister F; Chen W; Oriabure O; Badillo M; Jiang C; Yixin Y; Li S; Tang G; Yin CC; Patel KP; Medeiros LJ; Nair R; Ahmed S; Iyer SP; Thirumurthi S; Champlin R; Xu G; Tinsu P; Santos D; Wang R; Han G; Zhang J; Song X; Neelapu S; Romaguera J; Futreal A; Flowers C; Fowler N; Wang L; Wang ML
Blood Adv; 2020 Mar; 4(6):1038-1050. PubMed ID: 32191807
[TBL] [Abstract] [Full Text] [Related]
19. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
[TBL] [Abstract] [Full Text] [Related]
20. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
[Next]
